meglumine has been researched along with Dermatitis Medicamentosa in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, SN; Bist, P; Chan, JKY; Chen, Q; Choi, HW; Fan, Y; Gunawan, M; Huang, EK; Liu, M; Mencarelli, A; Tan, SY; Tan, WWS; Yong, KSM | 1 |
| López Aventín, D; Martín-Ezquerra, G; Pujol, RM; Villar García, J | 1 |
| Castillo, M; Hernandes, Mde A; Semelka, RC; Stallings, CG | 1 |
| Boudaya, S; Maalej, N; Masmoudi, A; Turki, H; Zahaf, A | 1 |
1 trial(s) available for meglumine and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Objective evaluation of acute adverse events and image quality of gadolinium-based contrast agents (gadobutrol and gadobenate dimeglumine) by blinded evaluation. Pilot study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child, Preschool; Contrast Media; Drug Eruptions; Female; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pilot Projects; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Vomiting; Young Adult | 2013 |
3 other study(ies) available for meglumine and Dermatitis Medicamentosa
| Article | Year |
|---|---|
A humanized mouse model to study mast cells mediated cutaneous adverse drug reactions.
Topics: Animals; Contrast Media; Disease Models, Animal; Drug Eruptions; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-3; Mast Cells; Meglumine; Mice; Mice, Inbred NOD; Mice, SCID; Mice, Transgenic; Nerve Tissue Proteins; Organometallic Compounds; Receptors, G-Protein-Coupled; Receptors, Neuropeptide | 2020 |
Immune reconstitution-associated cutaneous sarcoid-like eruption in a patient with previous disseminated cutaneous leishmaniasis: a diagnostic challenge.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Drug Eruptions; Granuloma; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Leishmaniasis, Diffuse Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sarcoidosis | 2014 |
[Adverse effects of intralesional Glucantime in the treatment of cutaneous leishmaniosis].
Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Disease Susceptibility; Drug Eruptions; Facial Dermatoses; Female; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Retrospective Studies; Risk Assessment; Sporotrichosis; Staphylococcal Skin Infections; Superinfection | 2006 |